Piramal Pharma (PPLPHARMA) Share Price Rises 14.71% to Rs 227.65 Today
- September 2, 2026
- Posted by: Kunal Singla
- Category: News
Piramal Pharma Share Price rose 14.71% on 28 October 2026. The stock was trading at Rs 227.65 as of 11:52:28 AM IST, against a previous close of Rs 198.45, a gain of Rs 29.20 per share. At this level the market capitalisation of Piramal Pharma stands at Rs 25,981.26 crore, according to latest Univest data.
Piramal Pharma operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. This note walks through the numbers behind the move: where the stock sits inside today’s range, how its valuation compares with the industry, and what the reported ratios say about the business behind the share price rise.
Piramal Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 227.65 |
| Previous Close | Rs 198.45 |
| Today's Move | Rs 29.2 (+14.71%) |
| Open | Rs 215.8 |
| High | Rs 228.85 |
| Low | Rs 208.85 |
| Market Capitalisation | Rs 25,981.26 crore |
| Market Cap Category | Large Cap |
Piramal Pharma Ltd. (PPLPHARMA) rose to Rs 227.65 from the previous close of Rs 198.45, a move of Rs 29.2 or 14.71%. The stock opened at Rs 215.8, reached a high of Rs 228.85, recorded a low of Rs 208.85.
Piramal Pharma Share Price Today stands at Rs 227.65, up Rs 29.20 or 14.71% from the previous close of Rs 198.45. The stock opened at Rs 215.80, touched a low of Rs 208.85 and a high of Rs 228.85. The open was Rs 17.35 above the previous close, and the day low of Rs 208.85 stayed Rs 10.40 above it. The last traded price is Rs 1.20 below the day’s high of Rs 228.85.
The price table under this heading lists each level. The day’s range from Rs 208.85 to Rs 228.85 is Rs 20.00 wide, and the current price sits near the top of it. The stock has added Rs 11.85 since the open of Rs 215.80, and it has traded above the previous close for the whole session so far.
Because the trading session was still open when this Piramal Pharma Share Price Update was written, these levels can change as trading continues. The 14.71% move is the verified fact of the day. What the price data establishes is the size of the move and its position inside the range.
A rising price tells only part of the story, so the next step is to look at the ratios that describe the business itself. The fundamentals below show how the valuation and returns behind the Piramal Pharma stock price rise compare with the industry.
Why Piramal Pharma Ltd. (PPLPHARMA) May Be Moving Today
Piramal Pharma Ltd. (PPLPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 25,981.26 crore |
| P/B Ratio | 3.3x |
| ROE | -4.04% |
| ROCE | 1.24% |
| EPS | Rs -2.36 |
| Book Value Per Share | Rs 60.13 |
| Dividend Yield | 0% |
Piramal Pharma Ltd. (PPLPHARMA) fundamental metrics show P/B 3.3x, ROE -4.04%, ROCE 1.24%. These figures provide context only and are not a buy or sell signal.
Piramal Pharma Ltd. has a market capitalisation of Rs 25,981.26 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at 3.3x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -4.04% and ROCE of 1.24%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -2.36, book value per share of Rs 60.13, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.74x, median ROE of 11.23%, median ROCE of 13.17%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Benchmark Median P/E | 30.74x |
| Benchmark Average P/E | 43.3x |
| Benchmark P/E Range | 3.21x to 577.05x |
| Company P/B Ratio | 3.3x |
| Benchmark Median P/B | 2.71x |
| Company ROE | -4.04% |
| Benchmark Median ROE | 11.23% |
| Company ROCE | 1.24% |
| Benchmark Median ROCE | 13.17% |
| Company Market Capitalisation | Rs 25,981.26 crore |
| Benchmark Median Market Cap | Rs 696.43 crore |
Piramal Pharma Ltd. (PPLPHARMA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Piramal Pharma Ltd. (PPLPHARMA) has a ROE of -4.04%, which is below the benchmark median of 11.23%, a difference of -135.98%. Piramal Pharma Ltd. (PPLPHARMA) has a ROCE of 1.24%, which is below the benchmark median of 13.17%, a difference of -90.58%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,18,204.09 | 34.91 | 4.88 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,40,780 | 86.02 | 14.25 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,73,828.11 | 82.48 | 9.53 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,520.92 | 25.79 | 4.32 | 19.69 | 21.39 |
| Laurus Labs Ltd. | LAURUSLABS | 1,11,304.32 | 105.74 | 20.5 | 18.31 | 18.2 |
Its ROE of -4.04% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 1.24% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Piramal Pharma Ltd. (PPLPHARMA) has a market capitalisation of Rs 25,981.26 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Piramal Pharma
- Price action: the stock rose 14.71% to Rs 227.65 from a previous close of Rs 198.45 and trades Rs 1.20 below its day high of Rs 228.85.
- Valuation: the P/B of 3.30 compares with an industry median of 2.71 and an average of 3.99.
- Returns: ROE of -4.04% and ROCE of 1.24% compare with the industry medians of 11.23% and 13.17%.
- Per-share data: EPS of Rs -2.36, book value of Rs 60.13 and a dividend yield of 0.00% give the base for the valuation multiple.
- Sector position: market capitalisation of Rs 25,981.26 crore is above the industry median of Rs 696.43 crore across 199 companies.
About Piramal Pharma
Piramal Pharma Ltd. is a company in the Pharmaceuticals & Drugs industry, part of the Healthcare sector. Pharmaceutical businesses sit in the part of the healthcare sector that develops and sells medicines.
This note therefore sticks to the sector and industry classification and the reported ratios. For later financial results and company updates, readers can follow the Piramal Pharma stock page on Univest.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Piramal Pharma share price rising today?
Ans. Today's price data shows a clear rise, with the stock trading in the upper part of its day range. The stock traded at Rs 227.65, up 14.71% from the previous close of Rs 198.45, with market capitalisation at Rs 25,981.26 crore.
What is the Piramal Pharma share price today?
Ans. Piramal Pharma share price was last at Rs 227.65 as of 28 October 2026 at 11:52:28 AM IST. That is a gain of Rs 29.20, or 14.71%, over the previous close of Rs 198.45.
What is the market capitalisation of Piramal Pharma?
Ans. Piramal Pharma market cap stands at Rs 25,981.26 crore at the current price of Rs 227.65. The industry median across 199 companies is Rs 696.43 crore, so the company sits well above that median.
What is the P/B ratio of Piramal Pharma?
Ans. The P/B ratio of Piramal Pharma is 3.30. The industry median is 2.71 and the average is 3.99, so the ratio sits above the median and below the average. The range across 195 companies runs from -25.49 to 22.27.
What are the ROE and ROCE of Piramal Pharma?
Ans. Piramal Pharma reports ROE of -4.04% and ROCE of 1.24%. The industry median ROE is 11.23% and median ROCE is 13.17%, so both returns sit below the benchmark medians for the same industry.
What are the EPS and book value of Piramal Pharma?
Ans. EPS is Rs -2.36 and book value per share is Rs 60.13. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share. The stock trades at a P/B ratio of 3.30.
Does Piramal Pharma pay a dividend?
Ans. According to latest Univest data, the dividend yield of Piramal Pharma is 0.00%. Dividend yield is historical data relating the payout to the current price, and it is not a guarantee of any future payout by the company.
How does Piramal Pharma compare with its peers?
Ans. Piramal Pharma has a P/B of 3.30 against peers between 4.32 and 20.50, and ROE of -4.04% against peers between 14.85% and 26.76%. Its market cap of Rs 25,981.26 crore is below each of the five peers shown.
Track Piramal Pharma Share Price on Univest
Use Piramal Pharma Ltd. (PPLPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Univest lets users track the live Piramal Pharma Share Price, fundamental ratios such as P/B, ROE and ROCE, 52-week levels and wider market insights in one place. The stock page carries the latest price, day range and valuation metrics, and the Univest peer pages make it simple to compare Piramal Pharma with other Pharmaceuticals & Drugs names. All of this is information, not advice.